These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36421315)

  • 21. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
    Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids.
    Giordano C; Barnini S; Tsioutis C; Chlebowicz MA; Scoulica EV; Gikas A; Rossen JW; Friedrich AW; Bathoorn E
    Int J Antimicrob Agents; 2018 Feb; 51(2):260-265. PubMed ID: 29097338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global prevalence of mutation in the
    Khoshbayan A; Narimisa N; Elahi Z; Bostanghadiri N; Razavi S; Shariati A
    Front Microbiol; 2024; 15():1386478. PubMed ID: 38912352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
    Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.
    D'Onofrio V; Conzemius R; Varda-Brkić D; Bogdan M; Grisold A; Gyssens IC; Bedenić B; Barišić I
    Infect Genet Evol; 2020 Jul; 81():104263. PubMed ID: 32105865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
    Longo LGA; de Sousa VS; Kraychete GB; Justo-da-Silva LH; Rocha JA; Superti SV; Bonelli RR; Martins IS; Moreira BM
    Int J Antimicrob Agents; 2019 Nov; 54(5):579-586. PubMed ID: 31479740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Carbapenemase-Producing
    Főldes A; Oprea M; Székely E; Usein CR; Dobreanu M
    Antibiotics (Basel); 2022 Aug; 11(9):. PubMed ID: 36139950
    [No Abstract]   [Full Text] [Related]  

  • 29. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.
    Pitt ME; Cao MD; Butler MS; Ramu S; Ganesamoorthy D; Blaskovich MAT; Coin LJM; Cooper MA
    J Antimicrob Chemother; 2019 Mar; 74(3):582-593. PubMed ID: 30445429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.
    Jayol A; Poirel L; Brink A; Villegas MV; Yilmaz M; Nordmann P
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4762-6. PubMed ID: 24914122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine.
    Wand ME; Bock LJ; Bonney LC; Sutton JM
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Colistin Heteroresistance among Multidrug-Resistant
    Braspenning AJMM; Rajakani SG; Sey A; El Bounja M; Lammens C; Glupczynski Y; Malhotra-Kumar S
    Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-occurrence of genes encoding carbapenemase, ESBL, pAmpC and non-β-Lactam resistance among Klebsiella pneumonia and E. coli clinical isolates in Tunisia.
    Ben Sallem R; Laribi B; Arfaoui A; Ben Khelifa Melki S; Ouzari HI; Ben Slama K; Naas T; Klibi N
    Lett Appl Microbiol; 2022 May; 74(5):729-740. PubMed ID: 35076956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam.
    Berglund B; Hoang NTB; Tärnberg M; Le NK; Svartström O; Khu DTK; Nilsson M; Le HT; Welander J; Olson L; Larsson M; Nilsson LE; Hanberger H
    Int J Antimicrob Agents; 2018 May; 51(5):789-793. PubMed ID: 29180281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca.
    Jayol A; Poirel L; Villegas MV; Nordmann P
    Int J Antimicrob Agents; 2015 Jul; 46(1):108-10. PubMed ID: 25982250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India.
    Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R
    Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan.
    Gharaibeh MH; Alyafawi DA; Elnasser ZA; Lafi SQ; Obeidat HM
    J Infect Public Health; 2022 Aug; 15(8):922-929. PubMed ID: 35878515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens.
    Crawford MA; Fisher DJ; Leung LM; Lomonaco S; Lascols C; Cannatelli A; Giani T; Rossolini GM; Doi Y; Goodlett DR; Allard MW; Sharma SK; Khan E; Ernst RK; Hughes MA
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae.
    Kim SJ; Ko KS
    Int J Antimicrob Agents; 2018 Sep; 52(3):425-429. PubMed ID: 29944953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin Resistance Mechanisms in Clinical
    Snyman Y; Whitelaw AC; Reuter S; Maloba MRB; Newton-Foot M
    Microb Drug Resist; 2021 Sep; 27(9):1249-1258. PubMed ID: 33571049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.